Mitochondrial Antioxidant SkQ1 Has a Beneficial Effect in Experimental Diabetes as Based on the Analysis of Expression of microRNAs and mRNAs for the Oxidative Metabolism Regulators

Diabetes mellitus and related complications are among the most important problems of the world-leading healthcare systems. Despite their priority, molecular and genetic aspects of diabetes pathogenesis are poorly understood; however, the involvement of oxidative stress in this process is undoubted....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuliya Dvoretskaya, Victor Glanz, Mariya Gryaznova, Mikhail Syromyatnikov, Vasily Popov
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/2a120dd58c924f3d8a8d97f413ef8175
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2a120dd58c924f3d8a8d97f413ef8175
record_format dspace
spelling oai:doaj.org-article:2a120dd58c924f3d8a8d97f413ef81752021-11-25T16:27:46ZMitochondrial Antioxidant SkQ1 Has a Beneficial Effect in Experimental Diabetes as Based on the Analysis of Expression of microRNAs and mRNAs for the Oxidative Metabolism Regulators10.3390/antiox101117492076-3921https://doaj.org/article/2a120dd58c924f3d8a8d97f413ef81752021-10-01T00:00:00Zhttps://www.mdpi.com/2076-3921/10/11/1749https://doaj.org/toc/2076-3921Diabetes mellitus and related complications are among the most important problems of the world-leading healthcare systems. Despite their priority, molecular and genetic aspects of diabetes pathogenesis are poorly understood; however, the involvement of oxidative stress in this process is undoubted. Rats with experimental diabetes induced by the intraperitoneal injection of alloxan were subjected to the antioxidant pre-therapy with a series of mitochondria-targeted 10-(6’-plastoquinonyl)decyltriphenylphosphonium (SkQ1) injections and analyzed for the expression of mRNAs and microRNAs by real-time quantitative polymerase chain reaction to identify potential predictors of diabetes. Animals that received SkQ1 before diabetes induction demonstrated lower blood glucose levels compared to the diabetic animals not subjected to the therapy. SkQ1 caused changes in the mRNA levels of genes involved in the cellular defense against free radicals, which indicates a beneficial effect of the pre-therapy. Moreover, similar changes were observed on the epigenetic level, as the microRNA expression patterns not only proved the SkQ1 efficacy but also correlated with the expression levels of their mRNA targets. Oxidative stress and macromolecule damage by free radicals are determining factors in diabetes, which suggests that strategies aimed at restoring the antioxidant status of the cell can be beneficial. Mitochondria-targeted antioxidant SkQ1 demonstrates positive effects on several levels, from the normalization of the blood glucose content to genetic and epigenetic changes. Our results can serve as a basis for the development of novel therapeutic and diagnostic strategies.Yuliya DvoretskayaVictor GlanzMariya GryaznovaMikhail SyromyatnikovVasily PopovMDPI AGarticlemitochondria-targeted antioxidantmicroRNAoxidative stress10-(6′-plastoquinonyl)decyltriphenylphosphoniumqPCRgene expressionTherapeutics. PharmacologyRM1-950ENAntioxidants, Vol 10, Iss 1749, p 1749 (2021)
institution DOAJ
collection DOAJ
language EN
topic mitochondria-targeted antioxidant
microRNA
oxidative stress
10-(6′-plastoquinonyl)decyltriphenylphosphonium
qPCR
gene expression
Therapeutics. Pharmacology
RM1-950
spellingShingle mitochondria-targeted antioxidant
microRNA
oxidative stress
10-(6′-plastoquinonyl)decyltriphenylphosphonium
qPCR
gene expression
Therapeutics. Pharmacology
RM1-950
Yuliya Dvoretskaya
Victor Glanz
Mariya Gryaznova
Mikhail Syromyatnikov
Vasily Popov
Mitochondrial Antioxidant SkQ1 Has a Beneficial Effect in Experimental Diabetes as Based on the Analysis of Expression of microRNAs and mRNAs for the Oxidative Metabolism Regulators
description Diabetes mellitus and related complications are among the most important problems of the world-leading healthcare systems. Despite their priority, molecular and genetic aspects of diabetes pathogenesis are poorly understood; however, the involvement of oxidative stress in this process is undoubted. Rats with experimental diabetes induced by the intraperitoneal injection of alloxan were subjected to the antioxidant pre-therapy with a series of mitochondria-targeted 10-(6’-plastoquinonyl)decyltriphenylphosphonium (SkQ1) injections and analyzed for the expression of mRNAs and microRNAs by real-time quantitative polymerase chain reaction to identify potential predictors of diabetes. Animals that received SkQ1 before diabetes induction demonstrated lower blood glucose levels compared to the diabetic animals not subjected to the therapy. SkQ1 caused changes in the mRNA levels of genes involved in the cellular defense against free radicals, which indicates a beneficial effect of the pre-therapy. Moreover, similar changes were observed on the epigenetic level, as the microRNA expression patterns not only proved the SkQ1 efficacy but also correlated with the expression levels of their mRNA targets. Oxidative stress and macromolecule damage by free radicals are determining factors in diabetes, which suggests that strategies aimed at restoring the antioxidant status of the cell can be beneficial. Mitochondria-targeted antioxidant SkQ1 demonstrates positive effects on several levels, from the normalization of the blood glucose content to genetic and epigenetic changes. Our results can serve as a basis for the development of novel therapeutic and diagnostic strategies.
format article
author Yuliya Dvoretskaya
Victor Glanz
Mariya Gryaznova
Mikhail Syromyatnikov
Vasily Popov
author_facet Yuliya Dvoretskaya
Victor Glanz
Mariya Gryaznova
Mikhail Syromyatnikov
Vasily Popov
author_sort Yuliya Dvoretskaya
title Mitochondrial Antioxidant SkQ1 Has a Beneficial Effect in Experimental Diabetes as Based on the Analysis of Expression of microRNAs and mRNAs for the Oxidative Metabolism Regulators
title_short Mitochondrial Antioxidant SkQ1 Has a Beneficial Effect in Experimental Diabetes as Based on the Analysis of Expression of microRNAs and mRNAs for the Oxidative Metabolism Regulators
title_full Mitochondrial Antioxidant SkQ1 Has a Beneficial Effect in Experimental Diabetes as Based on the Analysis of Expression of microRNAs and mRNAs for the Oxidative Metabolism Regulators
title_fullStr Mitochondrial Antioxidant SkQ1 Has a Beneficial Effect in Experimental Diabetes as Based on the Analysis of Expression of microRNAs and mRNAs for the Oxidative Metabolism Regulators
title_full_unstemmed Mitochondrial Antioxidant SkQ1 Has a Beneficial Effect in Experimental Diabetes as Based on the Analysis of Expression of microRNAs and mRNAs for the Oxidative Metabolism Regulators
title_sort mitochondrial antioxidant skq1 has a beneficial effect in experimental diabetes as based on the analysis of expression of micrornas and mrnas for the oxidative metabolism regulators
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/2a120dd58c924f3d8a8d97f413ef8175
work_keys_str_mv AT yuliyadvoretskaya mitochondrialantioxidantskq1hasabeneficialeffectinexperimentaldiabetesasbasedontheanalysisofexpressionofmicrornasandmrnasfortheoxidativemetabolismregulators
AT victorglanz mitochondrialantioxidantskq1hasabeneficialeffectinexperimentaldiabetesasbasedontheanalysisofexpressionofmicrornasandmrnasfortheoxidativemetabolismregulators
AT mariyagryaznova mitochondrialantioxidantskq1hasabeneficialeffectinexperimentaldiabetesasbasedontheanalysisofexpressionofmicrornasandmrnasfortheoxidativemetabolismregulators
AT mikhailsyromyatnikov mitochondrialantioxidantskq1hasabeneficialeffectinexperimentaldiabetesasbasedontheanalysisofexpressionofmicrornasandmrnasfortheoxidativemetabolismregulators
AT vasilypopov mitochondrialantioxidantskq1hasabeneficialeffectinexperimentaldiabetesasbasedontheanalysisofexpressionofmicrornasandmrnasfortheoxidativemetabolismregulators
_version_ 1718413125219254272